ARCA Pharmaceutical Companies By Shares Outstanding

Shares Outstanding
Shares OutstandingEfficiencyMarket RiskExp Return
1PFE Pfizer Inc
5.67 B
(0.11)
 1.40 
(0.15)
2NVO Novo Nordisk AS
3.37 B
(0.21)
 1.82 
(0.38)
3TAK Takeda Pharmaceutical Co
3.17 B
(0.15)
 0.87 
(0.13)
4AZN AstraZeneca PLC ADR
3.1 B
(0.29)
 1.49 
(0.43)
5MRK Merck Company
2.53 B
(0.20)
 1.15 
(0.23)
6SNY Sanofi ADR
2.51 B
(0.19)
 1.20 
(0.23)
7JNJ Johnson Johnson
2.41 B
(0.09)
 0.79 
(0.07)
8GSK GlaxoSmithKline PLC ADR
2.04 B
(0.26)
 1.45 
(0.38)
9BMY Bristol Myers Squibb
2.03 B
 0.18 
 2.00 
 0.35 
10NVS Novartis AG ADR
B
(0.22)
 0.97 
(0.21)
11ABBV AbbVie Inc
1.77 B
(0.06)
 2.05 
(0.12)
12VTRS Viatris
1.19 B
 0.10 
 2.27 
 0.23 
13TEVA Teva Pharma Industries
1.13 B
(0.07)
 1.77 
(0.13)
14LLY Eli Lilly and
899.32 M
(0.20)
 1.81 
(0.36)
15RDY Dr Reddys Laboratories
833.05 M
(0.17)
 1.32 
(0.23)
16ELAN Elanco Animal Health
494.35 M
(0.07)
 2.50 
(0.17)
17ZTS Zoetis Inc
451.16 M
(0.03)
 1.27 
(0.03)
18RPRX Royalty Pharma Plc
444.3 M
(0.10)
 1.00 
(0.10)
19BHC Bausch Health Companies
367.8 M
 0.16 
 3.16 
 0.50 
20OGN Organon Co
257.54 M
(0.30)
 1.85 
(0.55)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds. Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.